Cell and Bioscience

Scope & Guideline

Connecting Researchers to Transformative Discoveries

Introduction

Immerse yourself in the scholarly insights of Cell and Bioscience with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN-
PublisherBMC
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCELL BIOSCI / Cell Biosci.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Cell and Bioscience' aims to advance knowledge in the fields of cellular and bioscience research through the dissemination of high-quality research articles that span a wide range of topics. Its core focus includes understanding cellular mechanisms, interactions, and the underlying biological processes that affect health and disease.
  1. Cellular Mechanisms and Signaling Pathways:
    Research articles often explore intricate signaling pathways and cellular mechanisms, including the role of various proteins, RNA modifications, and metabolic processes in health and disease.
  2. Stem Cell Biology and Regenerative Medicine:
    The journal frequently publishes studies on stem cell biology, differentiation, and their therapeutic applications in regenerative medicine and tissue engineering.
  3. Cancer Biology and Therapeutics:
    A significant portion of the research focuses on cancer biology, examining tumor biology, metastasis, and exploring novel therapeutic strategies and biomarkers.
  4. Neuroscience and Neurodegenerative Diseases:
    The journal addresses various aspects of neuroscience, including neural development, neuroinflammation, and neurodegenerative diseases, contributing to a better understanding of brain-related disorders.
  5. Microbiology and Infectious Diseases:
    Research on host-pathogen interactions, immune responses, and the development of therapeutic interventions against infectious diseases is a prominent theme.
  6. Metabolism and Disease:
    Studies related to metabolic disorders, their cellular mechanisms, and potential therapeutic interventions are also key areas of focus.
The journal is currently witnessing the emergence of several trending themes that reflect the latest advancements in cellular and bioscience research. These themes indicate a shift towards interdisciplinary approaches and innovative methodologies.
  1. RNA Modifications and Epitranscriptomics:
    There is a growing emphasis on the role of RNA modifications, particularly m6A and other epitranscriptomic changes, in regulating gene expression and their implications in various diseases, including cancer and neurodegenerative disorders.
  2. Microbiome and Host Interactions:
    Research exploring the interplay between the microbiome and host health is on the rise, particularly its influence on metabolic diseases, immune responses, and cancer progression.
  3. Organoid Models for Disease Modeling:
    The use of organoid technology is increasingly prominent, providing innovative platforms for studying disease mechanisms and testing therapeutic interventions in a more physiologically relevant context.
  4. Immunotherapy and Cancer Immunology:
    Publications focusing on the mechanisms of immunotherapy, including the role of immune checkpoints and the tumor microenvironment, are trending as researchers seek to enhance treatment efficacy.
  5. Metabolic Reprogramming in Cancer:
    Emerging studies are increasingly focusing on the metabolic pathways in cancer cells, exploring how metabolic reprogramming contributes to tumorigenesis and resistance to therapies.
  6. Gene Editing Technologies and Applications:
    The application of CRISPR/Cas9 and other gene editing technologies is gaining traction, with research exploring their potential in therapeutic contexts and the ethical implications surrounding their use.

Declining or Waning

While 'Cell and Bioscience' continues to evolve, certain themes appear to be declining in frequency or prominence. This may reflect shifts in research priorities or advancements in related fields.
  1. Basic Mechanisms of Epithelial-Mesenchymal Transition (EMT):
    Although EMT has been a significant area of study in cancer biology, the frequency of publications focusing solely on the mechanistic aspects of EMT appears to be decreasing, possibly due to a shift towards more integrative approaches that encompass broader cellular interactions.
  2. Traditional Pharmacological Approaches:
    There is a noticeable reduction in studies highlighting traditional pharmacological interventions, as the journal's focus is increasingly leaning towards innovative therapies, including gene editing and personalized medicine.
  3. In Vitro Models of Disease:
    The use of conventional in vitro models is becoming less prominent, as researchers are moving towards more complex and physiologically relevant models such as organoids and 3D cultures.
  4. Single-Cell Analysis Techniques:
    While single-cell technologies have gained significant attention, the specific focus on traditional single-cell sequencing methods is waning, with a greater emphasis now on integrating these techniques with spatial transcriptomics.

Similar Journals

Protein & Cell

Fostering Global Knowledge Exchange in Biochemical Research
Publisher: OXFORD UNIV PRESSISSN: 1674-800XFrequency: 12 issues/year

Protein & Cell, published by Oxford University Press, is a distinguished international journal focusing on cutting-edge research in the fields of biochemistry, biotechnology, cell biology, and drug discovery. This open access journal, active since 2014, is dedicated to disseminating innovative findings that advance our understanding of protein functions and cellular processes, making it an essential resource for researchers, professionals, and students alike. With an impressive 2023 impact factor reflected in its Q1 ranking across multiple categories such as Biochemistry, Drug Discovery, and Cell Biology, 'Protein & Cell' stands at the forefront of scientific research, driving collaboration and discussion in the scientific community. Researchers can access the journal freely online, fostering a global exchange of knowledge and contributing to significant advancements in medicine and biotechnology. Located in the United Kingdom, the journal strives to be a pivotal platform for impactful research that influences future studies and applications.

BIOSCIENCE REPORTS

Fostering Innovation in Biological Research
Publisher: PORTLAND PRESS LTDISSN: 0144-8463Frequency: 6 issues/year

BIOSCIENCE REPORTS, published by Portland Press Ltd, is a prestigious journal dedicated to advancing the fields of biochemistry, biophysics, cell biology, and molecular biology. Founded in 1981, the journal has established itself as a vital resource for researchers and professionals, boasting a significant impact factor and high rankings within its categories, including Q2 in Biochemistry and Q1 in Biophysics as of 2023. The journal’s commitment to high-quality, peer-reviewed research ensures that it remains an influential platform for the dissemination of cutting-edge scientific findings. While it operates under a traditional subscription model, it offers various access options to accommodate the needs of the scientific community. With ongoing publication through 2024, BIOSCIENCE REPORTS continues to play a crucial role in shaping discussions in the life sciences and fostering innovative research in biology.

CELL RESEARCH

Pioneering Research for a Healthier Tomorrow
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

FEBS Journal

Exploring New Horizons in Molecular Biology
Publisher: WILEYISSN: 1742-464XFrequency: 24 issues/year

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

Cell Death & Disease

Exploring the frontiers of cell biology and therapeutic innovation.
Publisher: SPRINGERNATUREISSN: 2041-4889Frequency: 1 issue/year

Cell Death & Disease, published by SpringerNature, is a premier open-access journal dedicated to disseminating high-quality research on the mechanisms and implications of cell death, disease pathology, and therapeutic responses. Since its inception in 2010, the journal has quickly established itself within the top tier of academic publishing, achieving a notable impact factor and earning Q1 rankings in several critical categories including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, Immunology, and Medicine (miscellaneous). With its commitment to open access, Cell Death & Disease ensures that groundbreaking research is available to a global audience, fostering collaboration and advancing knowledge across disciplines. Residing at the forefront of crucial scientific discourse, this journal not only attracts submissions from leading researchers but also significantly influences the fields of molecular biology, immunology, and neurology. By bridging the gap between basic science and clinical applications, it provides vital insights for professionals, academicians, and students alike.

Frontiers in Bioscience-Landmark

Illuminating Pathways in Genetics and Immunology
Publisher: IMR PRESSISSN: 2768-6701Frequency: 12 issues/year

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

Journal of Molecular Cell Biology

Catalyzing discoveries in molecular and cell biology.
Publisher: OXFORD UNIV PRESSISSN: 1674-2788Frequency: 6 issues/year

The Journal of Molecular Cell Biology, published by Oxford University Press, is a leading platform for groundbreaking research in the fields of cell biology, genetics, and molecular biology. With an impact factor that places it in the Q1 and Q2 quartiles across key academic categories, this journal has become an essential resource for researchers and professionals committed to advancing our understanding of cellular mechanisms and genetic processes. Since becoming Open Access in 2019, it has enhanced the accessibility of high-quality research, fostering collaboration and knowledge sharing within the scientific community. The journal's Scopus rankings reflect its significant impact in the field, particularly in genetics and molecular biology, ranking within the top percentiles. With a convergence of research spanning from 2009 to 2024, the Journal of Molecular Cell Biology remains at the forefront of innovative discoveries and critical discussions, making it a vital resource for students, academics, and industry experts alike.

CELL PROLIFERATION

Empowering Global Collaboration in Cell Biology
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Pioneering Research in Biochemistry and Cell Biology
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

MOLECULAR MEDICINE

Empowering Research through Open Access Insights
Publisher: SPRINGERISSN: 1076-1551Frequency: 1 issue/year

MOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.